143 related articles for article (PubMed ID: 20387674)
1. [Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases].
Lazebnik LB; Konopliannikov AG; Kniazev OV; Parfenov AI; Tsaregorodtseva TM; Ruchkina IN; Khomeriki SG; Rogozina VA; Konopliannikova OA
Ter Arkh; 2010; 82(2):38-43. PubMed ID: 20387674
[TBL] [Abstract][Full Text] [Related]
2. [Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation].
Lazebnik LB; Kniazev OV; Konopliannikov AG; Parfenov AI; Ruchkina IN; Mikhaĭlova ZF; Tsaregorodtseva TM; Khomeriki SG; Rogozina VA; Gudkova RB; Shcherbakov PL; Konopliannikova OA
Eksp Klin Gastroenterol; 2010; (11):3-15. PubMed ID: 21485508
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.
Duijvestein M; Vos AC; Roelofs H; Wildenberg ME; Wendrich BB; Verspaget HW; Kooy-Winkelaar EM; Koning F; Zwaginga JJ; Fidder HH; Verhaar AP; Fibbe WE; van den Brink GR; Hommes DW
Gut; 2010 Dec; 59(12):1662-9. PubMed ID: 20921206
[TBL] [Abstract][Full Text] [Related]
4. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F
Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096
[TBL] [Abstract][Full Text] [Related]
5. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
6. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
10. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.
Levine DS; Fischer SH; Christie DL; Haggitt RC; Ochs HD
Am J Gastroenterol; 1992 Jan; 87(1):91-100. PubMed ID: 1728132
[TBL] [Abstract][Full Text] [Related]
12. [Optimization of cell therapy in patients with inflammatory bowel diseases].
Lazebnik LB; Knyazev OV; Parfenov AI; Ruchkina IN; Shcherbakov PL; Khomeriki SG; Konoplyannikov AG
Ter Arkh; 2012; 84(8):10-7. PubMed ID: 22994082
[TBL] [Abstract][Full Text] [Related]
13. [Application of allogeneic mesenchymal stem cells in complex patients treatment with ulcerative colitis].
Lazebnik LB; Konopliannikov AG; Parfenov AI; Kniazev OV; Parfenov AI; Ruchkina IN; Khomeriki SG; Rogozina VA; Konopliannikova OA; Tsaregorodtseva TM
Eksp Klin Gastroenterol; 2009; (5):4-12. PubMed ID: 20205326
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
15. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
16. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.
Parente F; Cucino C; Bollani S; Imbesi V; Maconi G; Bonetto S; Vago L; Bianchi Porro G
Am J Gastroenterol; 2000 Mar; 95(3):705-11. PubMed ID: 10710061
[TBL] [Abstract][Full Text] [Related]
17. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
Vucelic B
Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Ringdén O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lönnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Transplantation; 2006 May; 81(10):1390-7. PubMed ID: 16732175
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacoeconomic benefits of patients with ulcerative colitis treatment with help of mesenchymal stem cells].
Lazebnik LB; Guseĭn-Zade MG; Kniazev OV; Efremov LI; Ruchkina IN
Eksp Klin Gastroenterol; 2010; (3):51-9. PubMed ID: 20496790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
